A Danish Diabetes Risk Scope for Targeted Screening: The Inter99 study

Diabetes Care

Volumn 27, Issue 3, 2004, Pages 727-733

  Glümer, Charlotte ^a,b   Carstensen, Bendix ^a   Sandbæk, Annelli ^c   Lauritzen, Torsten ^c   Jørgensen, Torben ^b   Borch Johnsen, Knut ^a  

^a STENO DIABETES CENTER   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DENMARK; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEISURE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX DIFFERENCE; SYMPTOM; VALIDATION PROCESS;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DENMARK; DIABETES MELLITUS; FALSE NEGATIVE REACTIONS; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 18844465939     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.3.727     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998 (see Comment in Diabetes Care 22:650, 1999)
2. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998 (see Comment in Diabetes Care 22:650, 1999)
3. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003
4. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
5. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K: Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18:126-132, 2001
6. Glumer C, Jorgensen T, Borch-Johnsen K: Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335-2340, 2003
7. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
8. Dunstan DW, Zimmet PZ, Welborn TA, de Court, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE: The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829-834, 2002
9. Rosenbloom AL, Joe JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345-354, 1999
10. Claudi T, Midthjell K, Holmen J, Fougner K, Kruger O, Wiseth R: Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: the Nord-Trondelag Diabetes Study, Norway. J Intern Med 248:492-500, 2000
11. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1:1373-1376, 1980
12. Midthjell K, Kruger O, Holmen J, Tverdal A, Claudi T, Bjorndal A, Magnus P: Rapid changes in the prevalence obesity and known diabetes in an adult Norwegian population: the Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care 22:1813-1820, 1999
13. Williams DR, Wareham NJ, Brown DC, Byrne CD, Clark PM, Cox BD, Cox LJ, Day NE, Hales CN, Palmer CR, Shackleton JR, Wang TWM: Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30-35, 1995
14. American Diabetes Association: Screening for diabetes (Position Statement). Diabetes Care 25 (Suppl. 1):S21-S24, 2002
15. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BHR, Rutten G: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24:S6-S11, 2000
16. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (Tech. Rep. Ser., no. 99.2)
17. Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K: A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials: PRECARD and the Copenhagen risk score. J Cardiovasc Risk 8:291-297, 2001
18. Efron B, Tibshirani RJ: An introduction to the Bootstrap. New York, Chapman & Hall, 1993
19. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ: Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213-219, 1999
20. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE: A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382-387, 1995
21. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ: Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491-496, 1997
22. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ: Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164-171, 2000
23. Engelgau MM, Narayan KMV, Herman WH: Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000
24. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577, 1993
25. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
26. Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ: What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen 9:187-190, 2002